Stay updated on XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial

Sign up to get notified when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T13:58:33.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:18:10.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T20:37:01.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T20:41:18.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the expected study record content, indicating an access restriction. The usual navigation and study details are replaced by an error message.
    Difference
    17%
    Check dated 2026-09-20T20:45:25.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Prostate cancer and MedlinePlus Genetics were added as related topics to expand navigation and cross-references for readers.
    Difference
    0.2%
    Check dated 2026-09-13T21:58:55.000Z thumbnail image

Stay in the know with updates to XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.